Kamile Silay1, Ahmet Yalcin2, Sema Akinci3, Fatma Gul Gursoy4, Didem Sener Dede5. 1. Faculty of Medicine, Department of Internal Medicine and Geriatrics, Yildirim Beyazit University, Lodumlu Mevkii, No:3 Bilkent, 06030, Ankara, Turkey. kamilesilay@hotmail.com. 2. Department of Internal Medicine and Geriatrics, Ataturk Research and Training Hospital, Ankara, Turkey. 3. Department of Internal Medicine, Ataturk Research and Training Hospital, Ankara, Turkey. 4. Faculty of Medicine, Department of Family Medicine, Yildirim Beyazit University, Ankara, Turkey. 5. Faculty of Medicine, Department of Internal Medicine and Oncology, Yildirim Beyazit University, Ankara, Turkey.
Abstract
BACKGROUND: The aim is to evaluate the association between the Charlson Comorbidity Index (CCI), polypharmacy, inappropriate medication use and cognitive impairment in long-term care facility patients. METHODS: A cross-sectional study including 105 long-term care facility residents was performed. The Charlson Comorbidity Index (CCI) was used. Inappropriate drug use (IDU) was defined according to the STOPP (Screening Tool of Older People's Prescriptions) criteria. Univariate analysis to identify variables associated with patient outcome related with cognitive impairment was investigated with χ2, Pearson correlation, Fisher exact, and Mann-Whitney U test where appropriate. For the multivariate analysis, the possible factors identified with univariate analysis were further entered into logistic regression analysis. RESULTS: A significant difference was found between gender, CCI and cognitive impairment (p = 0.038, p = 0.01). While every one point increment in the CCI increases the risk of cognitive impairment 3.1 fold (95% CI = 1.8-5.4, p < 0.001), hypertension increases the risk 12 fold (95% CI = 2.5-67.8, p = 0.002). While the correlation between Mini-Mental Status Examination (MMSE) score and polypharmacy is significant (p = 0.015), the correlation between MMSE and IDU was insignificant (p = 0.739). The association of urogenital system drugs and dementia was significant (p = 0.044). CONCLUSIONS: Comorbidities, especially hypertension and old age, are risk factors for cognitive impairment. Polypharmacy correlates with MMSE and is considered a risk factor for cognitive impairment. Inappropriate medication use is high among long-term care facility residents. More studies on large cohorts are needed regarding optimal drug prescription and detection of specific drugs that may have an impact on cognitive performance.
BACKGROUND: The aim is to evaluate the association between the Charlson Comorbidity Index (CCI), polypharmacy, inappropriate medication use and cognitive impairment in long-term care facility patients. METHODS: A cross-sectional study including 105 long-term care facility residents was performed. The Charlson Comorbidity Index (CCI) was used. Inappropriate drug use (IDU) was defined according to the STOPP (Screening Tool of Older People's Prescriptions) criteria. Univariate analysis to identify variables associated with patient outcome related with cognitive impairment was investigated with χ2, Pearson correlation, Fisher exact, and Mann-Whitney U test where appropriate. For the multivariate analysis, the possible factors identified with univariate analysis were further entered into logistic regression analysis. RESULTS: A significant difference was found between gender, CCI and cognitive impairment (p = 0.038, p = 0.01). While every one point increment in the CCI increases the risk of cognitive impairment 3.1 fold (95% CI = 1.8-5.4, p < 0.001), hypertension increases the risk 12 fold (95% CI = 2.5-67.8, p = 0.002). While the correlation between Mini-Mental Status Examination (MMSE) score and polypharmacy is significant (p = 0.015), the correlation between MMSE and IDU was insignificant (p = 0.739). The association of urogenital system drugs and dementia was significant (p = 0.044). CONCLUSIONS: Comorbidities, especially hypertension and old age, are risk factors for cognitive impairment. Polypharmacy correlates with MMSE and is considered a risk factor for cognitive impairment. Inappropriate medication use is high among long-term care facility residents. More studies on large cohorts are needed regarding optimal drug prescription and detection of specific drugs that may have an impact on cognitive performance.
Authors: I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg Journal: Lancet Date: 1996-04-27 Impact factor: 79.321
Authors: H Chang-Quan; W Hui; W Chao-Min; W Zheng-Rong; G Jun-Wen; L Yong-Hong; L Yan-You; L Qing-Xiu Journal: Int J Clin Pract Date: 2011-12 Impact factor: 2.503
Authors: Minna K Löppönen; Raimo E Isoaho; Ismo J Räihä; Tero J Vahlberg; Saila M Loikas; Timo I Takala; Hannu Puolijoki; Kerttu M Irjala; Sirkka-Liisa Kivelä Journal: Dement Geriatr Cogn Disord Date: 2004-08-06 Impact factor: 2.959
Authors: Tammy T Hshieh; Wooram F Jung; Laura J Grande; Jiaying Chen; Richard M Stone; Robert J Soiffer; Jane A Driver; Gregory A Abel Journal: JAMA Oncol Date: 2018-05-01 Impact factor: 31.777
Authors: Mary Ganguli; Yichen Jia; Tiffany F Hughes; Beth E Snitz; Chung-Chou H Chang; Sarah B Berman; Kevin J Sullivan; M Ilyas Kamboh Journal: J Am Geriatr Soc Date: 2018-11-16 Impact factor: 5.562
Authors: Claudie Hooper; Philipe De Souto Barreto; Nicola Coley; Matteo Cesari; Pierre Payoux; Anne Sophie Salabert; Sandrine Andrieu; Bruno Vellas Journal: Front Med (Lausanne) Date: 2017-11-06
Authors: Miguel García-Grimshaw; Amanda Chirino-Pérez; Fernando Daniel Flores-Silva; Sergio Iván Valdés-Ferrer; María de Los Ángeles Vargas-Martínez; Ana Itiel Jiménez-Ávila; Oswaldo Alan Chávez-Martínez; Enrique Manuel Ramos-Galicia; Osvaldo Alexis Marché-Fernández; Martha Fernanda Ramírez-Carrillo; Samara Lissete Grajeda-González; Marco Eduardo Ramírez-Jiménez; Emma Adriana Chávez-Manzanera; María Teresa Tusié-Luna; Ana Ochoa-Guzmán; Carlos Cantú-Brito; Juan Fernandez-Ruiz; Erwin Chiquete Journal: Neurol Sci Date: 2022-01-13 Impact factor: 3.830